CJC-1295 (No DAC)/IPAMORELIN BLEND (5mg/5mg)

CJC-1295 (No DAC) / Ipamorelin Blend (5mg / 5mg) is a research-grade peptide formulation developed for laboratory and preclinical research applications. By combining two complementary peptides, this blend supports studies focused on growth hormone signaling pathways, receptor activity, and peptide interaction research. Researchers value this formulation for its consistency and versatility in controlled research environments.

CJC-1295 (No DAC) is commonly studied for its role in stimulating growth hormone–related signaling without extended binding activity. When paired with Ipamorelin, a selective peptide often examined for receptor-specific signaling behavior, the blend allows researchers to explore combined peptide dynamics within a single research protocol. As a result, laboratories can streamline experimental designs while maintaining precise control over peptide ratios.

Supplied in a 5mg / 5mg formulation, this blend allows accurate preparation of research solutions according to protocol requirements. In addition, the measured composition supports reproducibility across repeated experiments. Researchers benefit from improved workflow efficiency while reducing variability between study phases.

In laboratory settings, this peptide blend is frequently included in endocrine-related research models and growth hormone pathway investigations. For example, researchers may analyze how combined peptide signaling influences downstream cellular responses. Therefore, the blend is commonly used in in-vitro and preclinical studies focused on peptide-receptor interaction and signaling behavior.

Proper storage and handling remain essential to preserve peptide integrity. Laboratories should store this blend in a cool, dry environment, protected from light and moisture. Following standard sterile handling practices further supports product stability during preparation. Additionally, limiting repeated freeze–thaw cycles helps maintain consistent performance throughout the research lifecycle.

Common Research Applications

• Growth hormone signaling pathway research.
• Peptide and receptor interaction studies.
• Endocrine-related laboratory research.
• In-vitro and preclinical research models.
  

  KEY FEATURES

• Dual-peptide research blend with balanced formulation.
• Combines CJC-1295 (No DAC) and Ipamorelin at 5mg / 5mg.
• Commonly studied in growth hormone signaling research.
• Suitable for in-vitro and preclinical laboratory models.
• Consistent composition for reliable experimental results.
• Manufactured under strict quality control standards.
• Intended strictly for research use only (RUO).